Pages that link to "Q33947907"
Jump to navigation
Jump to search
The following pages link to Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer (Q33947907):
Displaying 50 items.
- The Obesity-Breast Cancer Conundrum: An Analysis of the Issues (Q26747486) (← links)
- Obesity and cancer: mechanistic insights from transdisciplinary studies (Q26786829) (← links)
- Role of n-3 Polyunsaturated Fatty Acids and Exercise in Breast Cancer Prevention: Identifying Common Targets (Q28066027) (← links)
- ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development (Q28115416) (← links)
- pETM: a penalized Exponential Tilt Model for analysis of correlated high-dimensional DNA methylation data (Q31159752) (← links)
- Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling. (Q33618393) (← links)
- Inhibitory effects of BMP9 on breast cancer cells by regulating their interaction with pre-adipocytes/adipocytes (Q33829349) (← links)
- Healthy Weight Loss for the Cancer Survivor (Q35687599) (← links)
- Circadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer. (Q35691235) (← links)
- The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming (Q35865881) (← links)
- Effect of obesity on molecular characteristics of invasive breast tumors: gene expression analysis in a large cohort of female patients (Q36009189) (← links)
- Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. (Q36118082) (← links)
- Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis (Q36183877) (← links)
- COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth. (Q36260630) (← links)
- COP9 signalosome subunit 6 (CSN6) regulates E6AP/UBE3A in cervical cancer (Q36413974) (← links)
- Weight loss reduces basal-like breast cancer through kinome reprogramming (Q36758643) (← links)
- CSN6 positively regulates c-Jun in a MEKK1-dependent manner (Q36780798) (← links)
- Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications. (Q36788273) (← links)
- Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. (Q36816526) (← links)
- Fibroblast growth factors, old kids on the new block (Q36923642) (← links)
- Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer (Q37190310) (← links)
- Obesity-associated NLRC4 inflammasome activation drives breast cancer progression (Q37330542) (← links)
- Insulin-like growth factor binding protein-3 links obesity and breast cancer progression. (Q37688258) (← links)
- Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered (Q38722530) (← links)
- Obesity and cancer: inflammation bridges the two. (Q38900947) (← links)
- A Comprehensive Lifestyle Randomized Clinical Trial: Design and Initial Patient Experience (Q39141443) (← links)
- Insights into the Link Between Obesity and Cancer (Q39256853) (← links)
- Alcohol consumption and breast tumor gene expression (Q40045112) (← links)
- Breast cancer in Angola, molecular subtypes: a first glance (Q41545885) (← links)
- Genetic variants in the mTOR pathway and interaction with body size and weight gain on breast cancer risk in African-American and European American women (Q41986669) (← links)
- Weight management and physical activity throughout the cancer care continuum. (Q47175816) (← links)
- Prospective evaluation of abnormal glucose metabolism and insulin resistance in patients with atypical endometrial hyperplasia and endometrial cancer (Q47597561) (← links)
- Targeting the SphK1/S1P/S1PR1 axis that links obesity, chronic inflammation and breast cancer metastasis. (Q47851281) (← links)
- Antitumor effects of metformin via indirect inhibition of protein phosphatase 2A in patients with endometrial cancer. (Q50000289) (← links)
- Anthropometric, metabolic and molecular determinants of human epidermal growth factor receptor 2 expression in luminal B breast cancer (Q51310879) (← links)
- Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2. (Q52655425) (← links)
- Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer. (Q55365837) (← links)
- Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment. (Q55396890) (← links)
- Novel Application of Metformin Combined with Targeted Drugs on Anticancer Treatment (Q57784984) (← links)
- A cancer-testis non-coding RNA LIN28B-AS1 activates driver gene LIN28B by interacting with IGF2BP1 in lung adenocarcinoma (Q57799073) (← links)
- Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues (Q58546150) (← links)
- OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers (Q59123158) (← links)
- Obesity-Linked Cancers: Current Knowledge, Challenges and Limitations in Mechanistic Studies and Rodent Models (Q60949486) (← links)
- Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms (Q61799036) (← links)
- CSN6: a promising target for cancer prevention and therapy (Q89524000) (← links)
- Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients (Q90431016) (← links)
- Impact of Diet and Nutrition on Cancer Hallmarks (Q90732589) (← links)
- SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia (Q92189680) (← links)
- miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2 (Q92668470) (← links)
- Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth (Q98726727) (← links)